Emerging Therapies for the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma
Skrabek, P.; Assouline, S.; Christofides, A.; MacDonald, D.; Prica, A.; Sangha, R.; Matthews, B.A.; Sehn, L.H. Emerging Therapies for the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma. Curr. Oncol. 2019, 26, 253-265. https://doi.org/10.3747/co.26.5421
Skrabek P, Assouline S, Christofides A, MacDonald D, Prica A, Sangha R, Matthews BA, Sehn LH. Emerging Therapies for the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma. Current Oncology. 2019; 26(4):253-265. https://doi.org/10.3747/co.26.5421
Chicago/Turabian StyleSkrabek, P.; Assouline, S.; Christofides, A.; MacDonald, D.; Prica, A.; Sangha, R.; Matthews, B.A.; Sehn, L.H. 2019. "Emerging Therapies for the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma" Curr. Oncol. 26, no. 4: 253-265. https://doi.org/10.3747/co.26.5421